The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of neutropenia with adjuvant epirubicin-CMF on survival in patients with node-negative or 1 to 3 node-positive rapidly proliferating breast cancer.
B. Kopf
No relevant relationships to disclose
E. Scarpi
No relevant relationships to disclose
O. Nanni
No relevant relationships to disclose
M. Faedi
No relevant relationships to disclose
L. Gianni
No relevant relationships to disclose
A. Rocca
No relevant relationships to disclose
W. Zoli
No relevant relationships to disclose
D. Amadori
No relevant relationships to disclose
U. De Giorgi
No relevant relationships to disclose